SHPH Stock Analysis: Buy, Sell, or Hold?
SHPH - Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$3.95
0.43 (12.23%)
▲
5d:
+4.92%
30d:
+544.08%
90d:
+345.26%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When SHPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SHPH is 45.6% above its trading range ($2.71). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SHPH is 45.6% above its trading range ($2.71). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SHPH is currently trading at $3.94, which is considered extended relative to its 30-day fair value range of $-0.11 to $2.71.
Technical Outlook: Technically, SHPH is in a strong downtrend. The price is approaching resistance at $0.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: SHPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SHPH is in a strong downtrend. The price is approaching resistance at $0.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 12.2% recently.
Market Sentiment: SHPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.11 -
$2.71
Company Quality Score
45/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BEARISH: Price significantly overextended (+45.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+12.2%)
- WARNING: Recommendation downgraded due to 45.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.11 -
$2.71
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.38
Resistance Level
$0.64
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Share & Embed Analysis
Last updated: June 23, 2026 3:32 PM ET
Data refreshes hourly during market hours. Next update: 4:32 PM
Data refreshes hourly during market hours. Next update: 4:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SHPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
